参考文献/References:
[1]刘永芳,王水花,陈帮明,等.152例IgA肾病中医体质类型与临床特征研究[J].中医临床研究,2012,4(18):11-13.[2]唐余燕,贺海东,徐旭东.micro-RNA调控低糖基化IgA1形成在IgA肾病中研究进展[J].中国中西医结合肾病杂志,2018, 19(3):270-272.[3]陆佳鑫,吴艳萍,石君华.黄芪治疗IgA肾病随机对照试验的Meta分析[J].湖北中医杂志,2019(8):63-64.[4]王宇.基于临床病理特征、中医证候的IgA肾病预后因素研究及中医药疗效评价[D].广州中医药大学,2018.[5]刘永芳,王水花,陈帮明,等.152例IgA肾病中医体质类型与肾脏病理特征研究[J].辽宁中医杂志,2013,40(1):15-17.[6]刘永芳,陈帮明,王金象,等.240例IgA肾病中医体质类型与本虚证的分布特征研究[J].中国中医药现代远程教育,2017,15(253):52-54.
相似文献/References:
[1]李 伟,陈素华.妊娠期人巨细胞病毒感染的中医药研究进展[J].医学信息,2019,32(01):37.[doi:10.3969/j.issn.1006-1959.2019.01.013]
LI Wei,CHEN Su-hua.Advances in Research on Traditional Chinese Medicine for Human Cytomegalovirus Infection during Pregnancy[J].Medical Information,2019,32(21):37.[doi:10.3969/j.issn.1006-1959.2019.01.013]
[2]刘 枫.IgA肾病与系膜增生性肾炎临床特征的比较[J].医学信息,2019,32(16):95.[doi:10.3969/j.issn.1006-1959.2019.16.029]
LIU Feng.Comparison of Clinical Features between IgA Nephropathy and Mesangial Proliferative Nephritis[J].Medical Information,2019,32(21):95.[doi:10.3969/j.issn.1006-1959.2019.16.029]
[3]黄 婷,张亚莉,李 燕,等.不同性别IgA肾病患者相关临床指标及病理特点对比[J].医学信息,2019,32(21):125.[doi:10.3969/j.issn.1006-1959.2019.21.040]
HUANG Ting,ZHANG Ya-li,LI Yan,et al.Comparative Analysis of Clinical and Pathological Features of Patients with Different Sex IgA Nephropathy[J].Medical Information,2019,32(21):125.[doi:10.3969/j.issn.1006-1959.2019.21.040]
[4]芶开来,李 明.中医药治疗股骨头坏死的临床研究现况[J].医学信息,2020,33(03):59.[doi:10.3969/j.issn.1006-1959.2020.03.018]
GOU Kai Lai,LI Ming.Clinical Research on Treatment of Femoral Head Necrosis with Traditional Chinese Medicine[J].Medical Information,2020,33(21):59.[doi:10.3969/j.issn.1006-1959.2020.03.018]
[5]江诗怡,陆定波.“肝病实脾”理论在治疗脂肪肝中的应用[J].医学信息,2020,33(03):154.[doi:10.3969/j.issn.1006-1959.2020.03.050]
[6]铉 力,王晓红,胡 兵.胡兵教授治疗胃癌前病变的经验举隅[J].医学信息,2020,33(03):158.[doi:10.3969/j.issn.1006-1959.2020.03.052]
XUAN Li,WANG Xiao-hong,HU Bing.Professor Hu Bing’s Experience in Treating Gastric Precancerous Lesion[J].Medical Information,2020,33(21):158.[doi:10.3969/j.issn.1006-1959.2020.03.052]
[7]刘 超,甘佳乐,冯丽丽,等.刘红旭教授治疗冠心病心绞痛的临床经验[J].医学信息,2022,35(04):165.[doi:10.3969/j.issn.1006-1959.2022.04.044]
[8]陈 越,彭 莉.黄芪对细胞毒素相关蛋白A诱导的大鼠系膜细胞外基质分泌的影响[J].医学信息,2022,35(15):104.[doi:10.3969/j.issn.1006-1959.2022.15.023]
CHEN Yue,PENG Li.Effect of Astragalus Membranaceus on CagA-induced Extracellular Matrix Secretion of Rat Mesangial Cells[J].Medical Information,2022,35(21):104.[doi:10.3969/j.issn.1006-1959.2022.15.023]
[9]郑桌龙,林 钢,罗勉那,等.成人IgA肾病免疫抑制治疗的研究进展[J].医学信息,2023,36(14):183.[doi:10.3969/j.issn.1006-1959.2023.14.040]
ZHENG Zhuo-long,LIN Gang,LUO Mian-na,et al.Research Progress on Immunosuppressive Therapy for IgA Nephropathy in Adults[J].Medical Information,2023,36(21):183.[doi:10.3969/j.issn.1006-1959.2023.14.040]
[10]袁茜宁,董怡晨,卿玲玲,等.不同蛋白尿水平IgA肾病患者的临床及病理特征分析[J].医学信息,2024,37(08):104.[doi:10.3969/j.issn.1006-1959.2024.08.020]
YUAN Qian-ning,DONG Yi-chen,QING Ling-ling,et al.Analysis of Clinical and Pathological Characteristics of IgA Nephropathy Patients with Different Proteinuria Levels[J].Medical Information,2024,37(21):104.[doi:10.3969/j.issn.1006-1959.2024.08.020]